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Abstract
Yes-associated protein 65 (YAP) contains multiple protein-protein interaction domains and functions as both a
transcriptional co-activator and as a scaffolding protein. Mouse embryos lacking YAP did not survive past embryonic day
8.5 and showed signs of defective yolk sac vasculogenesis, chorioallantoic fusion, and anterior-posterior (A-P) axis
elongation. Given that the YAP knockout mouse defects might be due in part to nutritional deficiencies, we sought to better
characterize a role for YAP during early development using embryos that develop externally. YAP morpholino (MO)-
mediated loss-of-function in both frog and fish resulted in incomplete epiboly at gastrulation and impaired axis formation,
similar to the mouse phenotype. In frog, germ layer specific genes were expressed, but they were temporally delayed. YAP
MO-mediated partial knockdown in frog allowed a shortened axis to form. YAP gain-of-function in Xenopus expanded the
progenitor populations in the neural plate (sox2
+) and neural plate border zone (pax3
+), while inhibiting the expression of
later markers of tissues derived from the neural plate border zone (neural crest, pre-placodal ectoderm, hatching gland), as
well as epidermis and somitic muscle. YAP directly regulates pax3 expression via association with TEAD1 (N-TEF) at a highly
conserved, previously undescribed, TEAD-binding site within the 59 regulatory region of pax3. Structure/function analyses
revealed that the PDZ-binding motif of YAP contributes to the inhibition of epidermal and somitic muscle differentiation,
but a complete, intact YAP protein is required for expansion of the neural plate and neural plate border zone progenitor
pools. These results provide a thorough analysis of YAP mediated gene expression changes in loss- and gain-of-function
experiments. Furthermore, this is the first report to use YAP structure-function analyzes to determine which portion of YAP
is involved in specific gene expression changes and the first to show direct in vivo evidence of YAP’s role in regulating pax3
neural crest expression.
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Introduction
Yes-associated protein 65 (YAP) contains multiple protein-
protein interaction domains and functions as both a transcriptional
co-activator and as a scaffolding protein. YAP was first identified
and named based on its association with the Src-family tyrosine
kinase and proto-oncogene, c-Yes [1]. YAP is a founding member
of the WW domain-containing protein family [2,3]. The WW
domain allows the binding of proteins containing a PPxY motif
[4]. Proteins shown to bind to YAP via its two WW domains
include: p53 family members (p73a, p73b, p63 [5]; Smad7 [6];
Runx2 [7]; and ErbB4 [8,9].
In addition to the two WW domains, YAP also contains other
protein-protein interaction domains (Figure 1A). Proteins that
interact at the N-terminus of YAP include hnRNP U, a nuclear
ribonucleoprotein shown to be important for RNA polymerase II
transcription [10,11], the TEA domain-containing transcription
factor (TEAD/TEF) family [12], and the Large tumor suppressor
(LATS). The phosphorylation event involving LATS via the
Hippo signaling pathway allows for the binding of 14-3-3, which
leads to the subsequent sequestration of YAP to the cytoplasm
[13]. At its C-terminus, YAP contains a postsynaptic density 95,
discs large, and zonula occludens-1 (PDZ)-binding motif that
allows for binding to PDZ domain-containing proteins.
Our initial interest in YAP came from the finding that YAP
bound to the second PDZ domain of Na(+)/H(+) exchanger
regulator factor 1/ezrin/radixin/moesin (ERM)-binding phospho-
protein of 50 kDa (NHERF1/EBP50) and co-localized to the
apical membrane of polarized airway epithelia along with CFTR
and c-Yes [14]. To determine the in vivo importance of this
scaffolding complex, we used homologous recombination to
remove YAP from the mouse and found that few embryos
survived past embryonic day 8.5, a much earlier time point than
would be expected for an associated lung development phenotype
PLoS ONE | www.plosone.org 1 June 2011 | Volume 6 | Issue 6 | e20309Figure 1. YAP morphant embryos exhibit defects in A-P axis elongation. (A) Frog and zebrafish YAP possess the ascribed functional and
protein-protein interaction domains, including the TEAD-binding site (purple), the LATS phosphorylation site (orange), the two WW domains (red) that
allow for PPxY binding, the Src Homology 3 (SH3)-binding domain (green), the coiled-coil region (blue), the transactivation domain (underline), andt h e
PDZ-binding motif (pink). hnRNP U (yellow) binding has only been experimentally tested with human YAP, but related sites are in the fish and frog
proteins. This diagramalsoillustrates the relativelocationof Xenopuslaevis(x) andDaniorerio (z) MO-bindingsites.(B) Injectionofanequimolar cocktail of
all three xYAP MOs at two concentrations (40 ng and 80 ng) resulted in efficient knockdown of endogenous, zygotic xYAP protein in stage 15 embryos as
measured by western blot analysis. EF-2 expression from the same blot served as the loading control. (C) Three different xYAP MOs (80 ng; see A for
binding sites) resulted in failed closure of the blastopore (arrows). (D) Reducing the concentration of the xYAP MO cocktail (left side) allowed blastopore
closure, but resulted in dose-dependent A-P axis shortening. (E) Time-lapsevideo microscopy showed that zYAP MO (16 ng) injectedembryos also exhibit
perturbation in the completion of gastrulation. Asterisks mark the tissue front of epiboly movements. In uninjected and cMO-injected embryos, this front
completelyenvelops the yolkby10 hours post-fertilization(hpf). Thesefrontsarestillin the equatorial regionin the 7.7–10 hpfYAP MO-injected embryos.
doi:10.1371/journal.pone.0020309.g001
YAP Expands Neural Progenitors and Regulates Pax3
PLoS ONE | www.plosone.org 2 June 2011 | Volume 6 | Issue 6 | e20309[15]. Detailed analyses of these mice illustrated that they suffered
from defects in yolk sac vasculogenesis, chorioallantoic fusion, and
anterior-posterior (A-P) axis elongation.
Given that YAP knockout mice struggled to progress normally
through early development, in part because of nutritional defi-
ciencies, we sought to better characterize a role for YAP during
this time period by using embryos that develop externally: Xenopus
laevis and Danio rerio. YAP morpholino (MO)-mediated complete
loss-of-function prevented the completion of epiboly, delayed
mesoderm induction, and severely impaired A-P axis elongation,
phenotypes that were similar to YAP
2/2 mice. YAP gain-of-
function experiments in Xenopus laevis expanded the progenitors of
the neural plate and neural plate border zone, while concomitantly
inhibiting expression of later markers of tissues derived from the
neural plate border zone (neural crest, pre-placodal ectoderm
(PPE), hatching gland), as well as epidermis and somitic muscle.
Through gain- and loss-of-function experiments and endogenous
chromatin immunoprecipitations (ChIP) for YAP, we show that
YAP directly regulates pax3 expression via association with
TEAD1 (N-TEF) and ultimately localizes to a highly conserved,
previously undescribed, TEAD-binding site within the 59 regula-
tory region of pax3. Finally, structure/function analyses revealed
that the PDZ-binding motif of YAP contributes to the inhibition of
epidermal and somitic muscle differentiation, but a complete,
intact YAP protein is required for expansion of the neural plate
and neural plate border zone progenitor pools.
Materials and Methods
Animal use and ethics statement
All experimental procedures described in this study followed the
U.S. Public Health Service Policy of Humane Care and Use of
Laboratory Animals and were approved by the Institutional Animal
Care and Use Committee at the National Institutes of Health
(NHLBI Animal Study Protocol: #H-0063), University of North
Carolina at Chapel Hill (IACUC ID: 10-277.0), and the George
Washington University (GWU Animal Study Protocol: #A-3205).
xYAP and morpholinos
A Xenopus laevis full-length cDNA clone (XL211h05) of yes-
associated protein 65 (xyap) was obtained from the National Insti-
tute for Basic Biology (Japan) and sequenced in both directions
(GenBank Accession #FJ979828). Three morpholinos, MO1
(GGA GGT GGG AGC TAG GAC AGC GG), MO2 (GGA
GAG GAC GCG GTA GGA GAC TGT G), and MO3 (GGG
CTC CAT GGC TGC GGG GAG GTG G), were designed to
the 59UTR of xyap for translational blocking (Fig. 1A; GeneTools).
Two splice blocking and putative early translational truncation
MOs, exon 1 (GTA GAG GAG CAT ATA CCT GCC GTG A)
and exon 2 (CCT GCA AAG AAC AAG TGG GAC AAT A)
(GeneTools) were designed across exon/intron boundaries. In vitro
translation reactions were performed using the TnT Quick Cou-
pled Transcription/Translation System (Promega), according to
the manufacturer’s protocol. Each MO (80 ng) was injected into in
vitro fertilized 1-cell Xenopus laevis embryos according to established
methods [16]. To observe phenotypes associated with lower MO
concentrations (0, 1.25, 2.5, 5, 10, 20, and 40 ng total), a cocktail
of all three (MO1, MO2, and MO3) translational blocking MOs
was injected into in vitro-fertilized 1-cell sibling embryos.
Cloning methods and constructs
For use in all of our gain-of-function analyses, we initially cloned
an HA tag (ATG TAC CCA TAC GAT GTT CCA GAT TAC
GCT) into the XhoI and EcoRV sites of the pSP64TXB vector so
that proper expression could be detected by western blot analysis.
xyap and xtead1 were subcloned in frame with the HA tag into the
EcoRV and NotI sites of the pSP64TXB-HA vector. A set of xYAP
mutant constructs, which included a constitutively active form of
xYAP (cActive xYAP) with a mutated LATS phosphorylation site
(S98A), a deletion (aa 61–81) of the TEAD-binding site (xYA-
PDTBS), a deletion (aa 78–161, aa 199–236) of the WW domains
(xYAPDWW), a deletion (aa 1–90) of the entire N-terminus
(xYAPDN), and a deletion (aa 455–459) of the PDZ-binding motif
at the C-terminus (xYAPDC), were also subcloned into the
pSP64TXB-HA vector at the EcoRV and NotI sites.
Gain-of-function analyses
For initial gain-of-function analyses, the animal poles of 1-cell
Xenopus laevis embryos were injected with 2 ng of in vitro-tran-
scribed ha-xyap mRNA (mMessage Machine, Ambion). For addi-
tional gain-of-function analyses, 2-cell Xenopus laevis embryos were
co-injected with 1 ng of in vitro-transcribed ha-xyap or ha-xyap
mutant mRNAs and 100 pg of in vitro-transcribed nls-b-galactosidase
mRNA into the lateral, animal pole of one of the two blastomeres.
Similarly, 100 pg of the in vitro-transcribed ha-xtead1 (xn-tef1) [17]
or 100 pg of ha-xyap mRNAs, were injected alone or in com-
bination. Every mRNA injection was repeated 2–4 times per
construct using different parental frogs to normalize against varia-
tion in genetic backgrounds and micropipette delivery. Results
from these independent experiments were then pooled.
Western blots
Embryos were injected at the 1-cell stage with a cocktail of the
three (MO1, MO2, and MO3) translational blocking xYAP
MOs (40 ng or 80 ng total) or the standard control MO (40 ng or
80 ng). These sibling embryos were allowed to develop until
control embryos reached stage 15. Whole embryo lysates were
snap frozen in a dry ice/ethanol bath and lysed in RIPA buffer
(50 mM Tris, pH 8.0, 150 mM NaCl, 1% NP-40, 0.5% sodium
deoxycholate, 0.1% SDS) containing a protease inhibitor cocktail
(Roche). Subsequently, Freon (1,1,2-trichlorotrifluoroethane, Sig-
ma-Aldrich) was used to remove the yolk from the samples, which
were then boiled for 5 min and stored at 280uC. Total protein
concentrations were quantified using the BCA Protein Assay Kit
(Pierce), according to the manufacturer’s protocol. Equal amounts
of protein were loaded onto a 10% SDS-PAGE gel, separated by
electrophoresis, transferred to a PVDF membrane, and probed for
xYAP using an affinity purified rabbit anti-YAP antibody (1:1000),
which was generated against human YAP (274–454) [10]. The
blots were then probed with a secondary HRP conjugated anti-
rabbit IgG antibody (1:10,000) (Jackson ImmunoResearch). The
blots were incubated in stripping buffer (62.5 mM Tris, 2% SDS,
0.1 M b-mercaptoethanol, pH 6.7) and re-probed for elongation
factor-2 (EF-2) using a goat anti-EF-2 antibody (1:500) (Santa
Cruz) and a secondary HRP-conjugated anti-goat IgG antibody
(1:4000) (Jackson ImmunoResearch).
zYAP and embryo manipulations
A Danio rerio full-length cDNA IMAGE clone 7066008 of yes-
associated protein 65 (zyap) (NM_001115121) was obtained from
Open Biosystems. A zYAP MO (59 CTC TTC TTT CTA TCC
AAC TGA AAC C 39) was designed to the 59 UTR of zyap
(GeneTools). In vitro translation reactions were performed using
the TnT Quick Coupled Transcription/Translation System
(Promega), according to the manufacturer’s protocol.
1-cell embryos were injected with 16 ng of the zYAP MO, a stan-
dard control MO(GeneTools),or 300 or 600 pg of invitro-transcribed
ha-zyap mRNA. Once embryos reached the 1000–2000-cell stage,
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on a custom fitted imaging mold (kindly supplied by Dr. Sean
Megason) [18] for time-lapse videography. Embryos were subse-
quently allowed to progress to the prim-11 stage and fixed.
qPCR
Xenopus laevis embryos were injected with 80 ng of the trans-
lational blocking xYAP MO cocktail or a control MO at the 1-cell
stage. When sibling control embryos reached stage 11, total RNA
was isolated using the Trizol reagent (Invitrogen), according to the
manufacturer’s protocol. RNA was quantified using a RiboGreen
RNA quantitation kit (Invitrogen), according to the manufactur-
er’s instructions. Total RNA (2 mg) was reverse transcribed using
Vilo cDNA synthesis (Invitrogen), according to the manufacturer’s
protocol. Then, qPCR was performed on a 7900HT 380-well
block Real-Time PCR system (Applied Biosystems) using Maxima
SYBR green qPCR master mix (Fermentas) on serial dilutions of
the RT product to ensure the efficiency of amplification with each
primer set was within 10% of one another. A relative quan-
tification study was performed using 5 mL of a 1:100 dilution of the
RT product, which was amplified using gene-specific primers:
brachyury (Forward: 59 TCT CTT TCA CAT GCT GTG CC 39,
Reverse: 59 GTG CCG TGA CAT CAT ACT GG 39); goosecoid
(Forward: 59 CAC ACA AAG TCG CAG AGT CTC 39, Reverse:
59 GGA GAG CAG AAG TTG GGG CCA 39); wnt8 (Forward: 59
TAT CTG GAA GTT GCA GCA TAC A 39, Reverse: 59 GCA
GGC ACT CTC GTC CCT CTG T 39); nodal-related 3 (nr3)
(Forward: 59 CGA GTG CAA GAA GGT GGA CA 39, Reverse:
59 ATC TTC ATG GGG ACA CAG GA 39); siamois (Forward: 59
AAG ATA ACT GGC ATT CCT GAG C 39, Reverse: 59 GGT
AGG GCT GTG TAT TTG AAG G 39); sox17a (Forward: 59
GCA AGA TGC TTG GCA AGT CG 39, Reverse: 59 GCT
GAA GTT CTC TAG ACA CA 39); sox11 (Forward: 59 GGC
TCT GGA TGA GAG TGA CC 39, Reverse: 59 TGA TGA
AGG GGA TTT TCT CG 39); h4 (Forward: 59 GGG ATA ACA
TTC AGG GTA TC 39, Reverse: 59 CAT GGC GGT AAC TGT
CTT C 39).
In situ hybridization and b-galactosidase staining
Xenopus laevis embryos were fixed in MEMFA, stained for
expression of a NLS-b-galactosidase lineage tracer, and processed
for whole mount in situ hybridization according to standard
protocols [16,19]. Anti-sense DIG-labeled RNA probes were
synthesized from the following plasmids: chordin (EcoRI, T7) [20],
eomesodermin (XhoI, T7) [21], brachyury (ClaI, T7) [22], vent2 (EcoRI,
T7) [23], not (HindIII, T7) [24], sox2 (HindIII, T7) [25], neuroD
(XhoI, T3) [26], n-tubulin (BamHI, T3) [27], p27
Xic1 (BamHI, T7)
[28], sox11 (SalI, T3) [29], six1 (NotI, T7) [30], notch (ClaI, Sp6)
[31], hes1 (SalI, T7) (Open Biosystems, BC070988), zic1 (EcoRI,
T3) [32], foxD3 (BamHI, T3) [33], and pax3 (SalI, T7) [25]. A full-
length probe for myoD was PCR amplified from a Xenopus laevis
(stage 19–26) cDNA library, which was kindly provided by Dr.
Aaron Zorn, using the following primers: forward (GGA CTA
GTA TGG AGC TGT TGC CCC CAC CAC TG) and reverse
(CGG AAT TCC TAT AAG ACG TGA TAG ATG GTG
CTG), and subcloned into the pBluescript SK(2) vector at the SpeI
and EcoRI sites. This myoD probe was then synthesized as
described above (SpeI, T7). Embryos derived from independent
microinjection experiments were processed independently for ISH
to normalize against processing variations.
Chromatin Immunoprecipitation (ChIP)
ChIP assays were performed with the ChIP-IT Express kit
(Active Motif) with some modifications. Three hundred stage
14–16 Xenopus laevis embryos were incubated, with gentle rolling,
in 10 ml of 1% formaldehyde/0.16 modified Barth’s solution
(MBS) for 30 min at room temperature to crosslink genomic DNA
and protein complexes. Crosslinking was stopped by incubating
the embryos in 125 mM glycine/0.16 MBS with gentle rolling.
Following two washes in 0.16 MBS, the embryos were snap-
frozen and stored at 280uC. Chromatin was sheared with a
Misonix 3000 cup horn by repeating 6 cycles of 30 sec: 1 sec pulse,
0.5 sec off at a power of 5. Samples rested on ice for 1 minute be-
tween each cycle. Shearing efficiency was determined by resolving a
reverse-crosslinked, precipitated sample of chromatin on a 1%
agarose gel. This sample wasquantifiedusing a Nanodrop,and12.5
or 25 mg of chromatin was subsequently immunoprecipitated for
4 hours with 2 mg of affinity-purified YAP antibody or rabbit IgG
(Genscript) in the presence of 0.25 mg/ml BSA and 0.1 mg/ml
herring sperm DNA. Beads were washed once with ChIP buffer 1
(Active Motif) and twice with ChIP buffer 2 (Active Motif) prior to
elution and proteinase K treatment. Five percent of the eluate was
used to amplify the pax3 promoter TEAD-binding site region using
the following xpax3-specific primers: forward (GCC TGA CAA
TGG CAC CTT AT) and reverse (AGG CGC ACT TGT GTG
ATT C). For subcloning this region, a proofreading DNA poly-
merase (cloned Pfu DNA polymerase, Stratagene) was used to PCR
amplify the product from the isolated YAP co-immunoprecipitated
Xenopus laevis genomic DNA. This PCR product was then gel-
purified from a 1% agarose gel. Alanines were then added back to
the ends using a non-proofreading DNA polymerase (Jumpstart
Taq polymerase, Sigma-Aldrich). The products were then ligated
into the pCRII-TOPO vector (Invitrogen) and sequenced.
Results
We previously showed that YAP
2/2 mice were embryonic
lethal and exhibited severe developmental abnormalities that
included defects in yolk sac vasculogenesis, chorioallantoic fusion,
and A-P axis elongation [15]. Given that these defects could be
due to nutritional deficiencies, we sought to better characterize a
role for YAP during early development by using Xenopus laevis and
Danio rerio, animal models for which the nutritional needs of the
embryos are self-contained. In addition, these embryos permit easy
knockdown of targeted protein expression via injection of gene-
specific MOs and efficient gain-of-function assessment via mRNA
injections.
YAP is required for progression through gastrulation
The full-length Xenopus laevis yap (xyap) EST encodes a protein
that is 78% identical to mouse YAP and contains all the described
protein-protein interaction domains, as well as the transcriptional
activation domain (Figure 1A). Isolation of Xenopus laevis genomic
DNA and subsequent PCR validated that our RT-PCR primer
design amplified a PCR product across exon-intron boundaries
(data not shown). RT-PCR and western blot analyses revealed
that xYAP mRNA and protein are maternally expressed in the
unfertilized egg through blastula stages, and are abundantly ex-
pressed from the onset of zygotic transcription (at mid-blastula
transition) through tadpole stages (Figure S1). These results are
consistent with reports of ubiquitous maternal mRNA expression
in Xenopus tropicalis, zebrafish and mouse, and widespread zygotic
expression in multiple neural, neural crest, and mesoderm derived
tissues, but limited expression in endoderm derived tissues of the
post-gastrulation embryo [15,34,35,36,37].
Three xYAP MOs were designed around the translational start
site (Figure 1A) and their efficacies were confirmed in vitro (data not
shown). An antibody directed against the C-terminus (274–454) of
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cold in vitro-translated xYAP product and stage 15 whole embryo
lysates (data not shown). We used this hYAP antibody to test the
efficacy of our xYAP MOs in vivo. Lysates from stage 15 MO-
injected embryos showed efficient knockdown of endogenous,
zygotic xYAP protein expression to undetectable levels (Figure 1B),
thus effectively mimicking the genetic knockout achieved in
mouse [15].
In vitro-fertilized sibling Xenopus laevis embryos that were injected
with 80 ng of any one of these xYAP MOs at the one-cell stage
failed to complete epiboly and close the blastopore (MO1, n=200,
100%; MO2, n=185, 100%; MO3, n=191, 100%), while
uninjected (n=349) and control MO-injected (n=231) embryos
progressed through gastrulation unexpurgated (Figure 1C). Fur-
thermore, these xYAP MO-injected embryos arrested at the open-
blastopore stages, demonstrating incomplete epiboly. The same
effect was observed using 40 ng (n=725, 100%) and 80 ng
(n=352, 100%) of an equimolar cocktail of all three translation-
blocking MOs (data not shown), both of which eliminated detec-
tion of endogenous, zygotic xYAP protein expression (Figure 1B).
A similar, but less robust, phenotype was achieved with xYAP
splice MOs targeted to exon 1 (n=328, 76%) and exon 2 (n=131,
77%). The less penetrant phenotype observed with the xYAP
splice MOs correlated with their reduced efficiency at knocking
down endogenous, zygotic protein expression (Figure S2). To-
gether, these results demonstrate the specificity of the xYAP MOs.
Reducing the concentration of the xYAP MO cocktail below
40 ng resulted in partial endogenous, zygotic YAP protein expression
(data not shown). This concomitantly allowed blastopore closure, but
resulted in dose dependent A-P axis elongation defects (Figure 1D).
Embryos injected with 1.25 ng (n=113) or 2.5 ng (n=142) of the
xYAP translation blocking MO cocktail appeared unaffected,
whereas embryos injected with 5–20 ng (5 ng, n=152; 10 ng,
n=155; 20 ng, n=163) of this cocktail did not progress through
gastrulation as rapidly as their control siblings, and had progressively
shortened body axes (Figure 1D). A similar phenotype was reported
for a 5–7.5 ng YAP MO dose in zebrafish embryos [36].
Although the defective blastopore closure phenotype was re-
producible using three different translational blocking xYAP
MOs individually or in combination as well as two different splice
blocking xYAP MOs, the phenotype was not rescued by co-
injecting 2 ng of frog (xyap), mouse (myap), or human (hyap)
mRNAs, even though they all were properly translated in Xenopus
laevis embryos (Figure S3). Therefore, we tested whether
knockdown of YAP in another animal model, using similar
methods, would produce a similar phenotype. Jiang et al.
previously showed that a low dose of YAP MO that reduced
fluorescence of a YAP 59UTR-eGFP reporter resulted in
shortened embryos with small heads; however, these embryos
were only analyzed at late stages (30–50 hpf) and thereby did not
address the gastrulation defects observed in frog YAP morphants
[36]. Therefore, we injected 16 ng of a zYAP MO into fertilized
one-cell zebrafish embryos, which completely eliminates expres-
sion of zYAP in an in vitro translation assay (data not shown).
Time-lapse videography showed that in the absence of zYAP
epiboly movements were arrested (Figure 1E). While the tissue
front of epiboly gradually closed around the yolk cell between
5.25–10 hpf in uninjected and control MO-injected embryos
(n=15 per each group), this closure was not achieved in YAP
morphants (n=15; 100%). Thus, in three different verte-
brates, loss of early YAP function interferes with the developmen-
tal networks that regulate completion of gastrulation movements.
To determine whether the MO-mediated gastrulation defects
correlated with an effect on genes required for germ-layer
formation, we performed qPCR analyses on well-established
markers of each germ layer. Control MO (80 ng) or the xYAP
MO cocktail (80 ng) were injected into one-cell Xenopus laevis
embryos, and the embryos were collected when uninjected siblings
reached mid-gastrulation (stage 11), a stage when germ layer
markers are abundantly expressed. Genes normally expressed in
the organizer at the onset of gastrulation were either unaffected
(siamois) or moderately increased (nodal-related 3). In contrast, the
expression levels of endodermal (sox17,p ,0.013), neural ectoder-
mal (sox11,p ,0.021), and three out of five mesodermal (brachyury,
p,0.013; goosecoid,p ,0.011; wnt8 p,0.018) genes were signifi-
cantly reduced in YAP MO-injected embryos (Figure 2A).
However, analyses of several mesodermal markers by in situ hybri-
dization in Xenopus laevis showed that these quantitative changes
resulted from delayed expression rather than loss of mesoderm
induction. While brachyury, eomesodermin, and chordin expression was
markedly reduced in xYAP MO-injected embryos compared to
sibling stage 11 embryos (Figure 2B), at sibling stage 13 these
genes, as well as several others, were expressed in patterns similar
to control stage 11 embryos (Figure 2B, n=14–25 per sample,
100% for all markers). Thus, eliminating endogenous, zygotic
xYAP protein expression does not prevent mesodermal gene in-
duction, but does delay the expression of a number of mesodermal
genes. These results indicate that the lack of progression through
gastrulation in YAP morphant embryos is not due to a failure in
germ layer inductions.
YAP gain-of-function also causes axis elongation defects
From these results, we predicted that increasing YAP protein
above endogenous levels may cause gastrulation to be completed
more rapidly. However, time-lapse video recordings of gastrula-
tion movements in zebrafish embryos injected with two different
doses of zyap mRNA did not detect any differences in the amount
of time required for epiboly movements to close around the yolk
plug (Figure 3A, n=5 per group). When these zyap mRNA
injected embryos developed to later stages, however, significant
perturbations were observed (Figure 3B, 300 pg, n=111, 100%;
600 pg, n=94; 100%), including shortened A-P body axis and
perturbed somitic and head morphologies. Likewise, injection of
xyap, myap,o rhyap (2 ng) mRNAs all caused similar phenotypes in
Xenopus laevis embryos (Figure 3C; n=155 (xyap), n=102 (myap),
n=93 (hyap), 100% affected). While these gain-of-function
phenotypes resemble the reduced YAP phenotypes reported in
zebrafish [36] and frog (Figure 1D), analysis of gene expression
(next section) indicates that YAP gain-of-function and loss-of-
function results in strikingly different effects. Since these late
phenotypes likely result from early alterations in tissue patterning
and/or A-P axis formation, and given that YAP is a well-described
transcriptional co-activator, we predicted that altering YAP levels
would have distinct effects on the expression of genes involved in
these early developmental processes.
YAP expands neural progenitors and inhibits neural
differentiation
Vertebrate A-P axis elongation is accomplished in part by
elongation of the neural plate [38,39], and in Xenopus and zebrafish
neurulae, yap mRNA is robustly expressed in the floor plate
and lateral borders of the neural plate [36,40]. Therefore, we
investigated whether neural progenitor fields were altered in YAP
gain-of-function Xenopus laevis embryos. Given that our previous
YAP gain-of-function experiments were injected into 1-cell Xenopus
laevis embryos, we chose to more closely monitor where our
injected mRNA ended up in the embryo by co-injecting xyap and
b-galatosidase (b-gal; as a lineage tracer) mRNAs into one
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PLoS ONE | www.plosone.org 5 June 2011 | Volume 6 | Issue 6 | e20309Figure 2. Germ layer markers are expressed in YAP morphant Xenopus embryos, but are temporally delayed. (A) qPCR analysis of
mRNA from uninjected, control MO-injected, and xYAP MO-injected Xenopus embryos collected when controls reached stage 10.5/11. brachyury,
goosecoid, wnt8, sox11, and sox17 mRNA levels were reduced, nodal-related 3 (nr3) mRNA levels were increased and siamois mRNA levels remained
unchanged in xYAP morphant embryos. (B) In situ characterization of mesoderm gene expression in uninjected, control MO-, and xYAP MO-injected
Xenopus embryos. xYAP morphant embryos express each gene in the correct location, but the spatial pattern resembles an earlier developmental
stage. For example, brachyury expression in the stage 11 YAP MO embryos is only faintly detected and brachyury expression in the stage 13 YAP MO
embryo is indistinguishable from the control stage 11 pattern. chordin expression in the stage 13 YAP MO embryo remains confined to the dorsal
blastopore lip (arrow), as is normal at stage 11; it has not elongated with the axial mesoderm as is normal at stage 13. eomesodermin expression in the
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indicated by sox2 expression, was expanded as evidenced by a
darker, longer, and/or wider expression domain compared to the
uninjected side of the same embryo (Figure 4A). Injection of the
YAP MO cocktail (40 ng) caused a loss of sox2 expression on the
injected side (Figure 4A), indicating that the YAP gain-of-function
and loss-of-function phenotypes are manifested early in body axis
formation by different mechanisms. Expansion and perdurance
of sox2 expressed resulted in concomitant repression of neural
differentiation markers (Figure 4B). neuroD, a bHLH neural dif-
ferentiation transcription factor, p27
Xic1, a cdk inhibitor shown to
be important for cell cycle exit and subsequent neural differen-
tiation [28], and n-tubulin, a post-mitotic neuron-specific tubulin,
each were strongly repressed (Figure 4B). These results are
consistent with a study in the chick neural tube demonstrating that
phosphorylated YAP is expressed in the sox2
+ ventricular zone,
and that electroporation of YAP increased the sox2
+ domain,
decreased the number of neuron-specific tubulin positive cells and
reduced cell cycle exit [41]. Interestingly, we also observed that the
expression of a muscle-specific bHLH differentiation marker,
myoD, was strongly repressed (n=52, 68%) (Figure 4D) indicating
that the effects of YAP were not confined to the neural ectoderm.
It is well documented that increased Notch expression and/or
signaling correlates with increased numbers of neural progenitors,
decreased differentiated neurons [31,42,43], and increased YAP
expression [44]. Therefore, we were surprised to observe that
xYAP gain-of-function reduced the mRNA levels of notch and hes1,
a direct Notch signaling target gene [45,46,47] (Figure 4C). These
Figure 3. zYAP and xYAP gain-of-function results in similar body axis defects. (A) Time-lapse videomicroscopy shows that zYAP gain-of-
function does not alter the timing of gastrulation movements, as evidenced by the progression of epiboly (asterisks mark the fronts of tissue
movement around the yolk). (B) zYAP gain-of-function in Danio rerio embryos resulted in head and eye deformities and shortened, malformed body
axes. Examples of two different mRNA doses are shown. (C) Injection of Xenopus (x), mouse (m), or human (h) yap mRNAs into Xenopus embryos all
showed phenotypes similar to those in zebrafish.
doi:10.1371/journal.pone.0020309.g003
stage 11 YAP MO embryo remains on the surface in the uninvoluted mesoderm (arrow), whereas in controls, eomesodermin-expressing cells have
migrated internally [21]. In the stage 11 panel, all views are vegetal; in the stage 13 panel, the views of brachyury and vent2 embryos and of the YAP
MO chordin embryos are vegetal and the remainder are dorsal.
doi:10.1371/journal.pone.0020309.g002
YAP Expands Neural Progenitors and Regulates Pax3
PLoS ONE | www.plosone.org 7 June 2011 | Volume 6 | Issue 6 | e20309results indicate that YAP’s ability to repress neural differentiation
is likely independent of Notch signaling.
The expansion of neural progenitors by increased YAP levels
also reduced the expression domain of the differentiated
epidermis, as marked by an epidermal-specific cyto-keratin [48]
(Figure 5B). Because interactions between the neural plate and the
epidermis lead to the formation of a neural plate border zone that
gives rise to the precursors of the peripheral nervous system, the
neural crest and the pre-placodal ectoderm (PPE) [49], we
analyzed whether these tissues were properly induced at neural
plate stages. While the pax3
+ domain surrounding the neural plate,
which is required to specify neural crest [50,51]), was expanded
(Figures 5D, 6A), two genes expressed by premigratory neural
crest (foxD3; zic1; [33,51]) and two PPE genes (six1, sox11; [52])
were dramatically reduced (Figure 5A, B). In addition, the pax3
+
precursors of the hatching gland [51] were virtually eliminated
(Figure 5D). Thus, in xyap-mRNA injected embryos the three
different precursor populations that contribute to the formation of
peripheral cranial structures did not develop at neural plate stages.
To determine whether the placode and neural crest populations
eventually develop, we targeted xyap-mRNA injections to the
neural plate border zone blastomere precursors (blastomeres D12
and V12; [53]). At tail bud stages: 1) placode expression of six1 was
significantly reduced in the otocyst (Figure 5E) and the olfactory
placode (data not shown); 2) foxD3-expressing neural crest cells
were more dorsally located than in controls, indicating delayed
migration into the periphery (Figure 5F); and 3) trigeminal placode
expression of neuroD was reduced (Figure 5G). The perturbations
in the differentiation of these precursors of peripheral cranial
structures likely account for the cranial defects seen in the YAP
gain-of-function late stage frog and fish embryos (Figure 3B, C).
YAP cooperates with TEAD to expand pax3
+ neural crest
progenitors
While the pax3
+ hatching gland cells were virtually eliminated,
pax3 expression in the neural plate border zone that is required for
neural crest specification [50] was extended, broadened, and/or
stronger compared to the uninjected, control side of the embryo
(Figures 5D, 6A). This expansion of the pax3
+ neural crest
progenitor field was concomitant with a decrease in genes
expressed by specified, premigratory neural crest (zic1, foxD3;
Figure 5B), suggesting that increased YAP holds these cells in a
progenitor, undifferentiated state longer than in an unmanipulated
embryo. Consistent with these gain-of-function results, embryos
that were injected with the xYAP MO cocktail (40 ng) exhibited a
complete loss of pax3 expression (Figure 6B). The loss of pax3 in the
Figure 4. xYAP gain-of-function expands neural progenitor fields, while neural differentiation is inhibited. (A) The neural plate
progenitor field marked by sox2 expression (blue stain) was darker, longer, and/or wider on the xYAP-injected side (arrow, red b-gal staining)
compared to the uninjected side of the same embryo. xYAP MO-mediated knockdown (40 ng) eliminated sox2 expression on the injected side,
whereas a control MO (cMO) did not. In this and all subsequent panels: n=sample size; %=frequency of the phenotype; arrow indicates injected side.
(B) Three genes indicative of neural differentiation (neuroD, n-tubulin, p27
Xic1) were inhibited by xYAP gain-of-function. (C) xYAP gain-of-function
reduced notch and hes1 expression. (D) Muscle differentiation marker, myoD, was reduced by xYAP gain-of-function. All views are dorsal-anterior.
doi:10.1371/journal.pone.0020309.g004
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could be rescued with xyap mRNA (Figure 6B).
In both frog and chick, the underlying mesoderm plays an
important role in specifying the tissues derived from the neural
plate border zone (reviewed in [54]. Therefore, it is possible that
the expansion of the pax3
+ neural crest is secondary to YAP effects
in the mesoderm. A recent study showed that it is the intermediate
mesoderm, which lies directly underneath the neural plate border
zone during neurulation, that is required for induction and main-
tenance of neural crest fate [55]. Therefore, we tested whether
YAP activity in the intermediate mesoderm causes expansion of
pax3 neural crest expression by targeting xyap-mRNA injections
to the blastomere lineage that gives rise to the intermediate
mesoderm but does not contribute to the neural crest (blastomere
V21, [53]). In these embryos, pax3
+ neural crest expression was
expanded in only 1/25 embryos (Figure 6C), supporting the
suggestion that YAP directly affects pax3 expression.
Much of the in vivo transcriptional co-activator activity of YAP
results from interactions with members of the TEAD transcription
factor family [56]. Recently, Naye et al. characterized two Xenopus
TEADs, xtead1 (xn-tef) and xtead3 (xd-tef) [17]. Injection of xtead1
(100 pg) mRNA alone expanded the pax3
+ neural crest progen-
itors, while a low dose of xyap (100 pg) mRNA alone had little
effect (Figure 6D). However, upon co-injection of equal amounts
of xtead1 (100 pg) and xyap (100 pg) mRNAs, the percentage of
embryos with an expansion of pax3
+ neural crest progenitors was
greatly increased (Figure 6D), indicating cooperativity between
these proteins. Although TEAD gain-of-function alone expanded
the pax3
+ neural crest progenitors, the above experiments show
that YAP enhances this effect, and the YAP MO experiments in-
dicate that YAP is required for this effect. Therefore, we predicted
that YAP acts as a transcriptional co-factor with xTEAD1 in
regulating pax3 expression.
Results from a series of pax3 promoter transgenic deletions led
Milewski et al. to suggest that a TEAD-binding site within a neural
crest enhancer region was responsible for neural crest expression
of pax3 [57]. However, we failed to find conservation of this
previously described TEAD-binding site in the Xenopus tropicalis
genome (Figure 7A). Using the genomic alignment and conserved
transcription factor binding site prediction program, ConTra [58],
a predicted TEAD-binding site that was highly conserved in 15
different vertebrates was identified 58 base pairs upstream of the
previously described mouse neural crest enhancer TEAD2-
binding site (Figure 7A). To demonstrate direct involvement of
xYAP in the control of pax3 transcription, we performed a ChIP
analysis of the xpax3 promoter from wild-type stage 14–16 Xenopus
laevis embryo DNA that was sheared to an appropriate size
(Figure 7B). Using primers made specifically to amplify the geno-
mic region containing the conserved TEAD-binding site (yellow
box in Figure 7A), endogenous xYAP co-immunoprecipitated with
this region, illustrating the direct involvement of xYAP in
regulating xpax3 transcription (Figure 7C). This TEAD-binding
site was specific since primers to another portion of the pax3
promoter were not pulled down with the YAP antibody (Figure
S4A). Likewise, a region of the sox2 promoter, which possesses a
putative TEAD-binding site, also failed to be pulled down with the
YAP antibody (Figure S4B). To confirm the presence of the
TEAD-binding site within the YAP chromatin-immunoprecipitat-
ed piece of Xenopus laevis genomic DNA, a proofreading Taq
polymerase was used to amplify and subclone the product
(Figure 7D). Interestingly, the conserved TEAD-binding site, but
not the proposed mouse TEAD2-binding site, was located in this
amplified fragment (Figure 7D).
PDZ-binding motif of xYAP plays a role in epidermal and
muscle differentiation
To better define which protein-protein interaction domain of
xYAP is responsible for the expansion of the neural plate and
Figure 5. xYAP gain-of-function inhibits the expression of
genes in the pre-placodal ectoderm, epidermis, premigratory
neural crest, and hatching gland. (A) Genes expressed in the pre-
placodal ectoderm (PPE), sox11 and six1, are dramatically reduced on the
xYAP-injected sides (arrows). Brackets indicate the laterally located PPE
expression domains on both sides the embryos. Anterior views. (B)
Expression of the epidermis-specific cyto-keratin gene is lost on the xYAP-
injected side. Anterior view. (C) The expression of genes characteristic of
premigratory neural crest (foxD3, zic1 at bracket) are repressed on the
xYAP-injected sides. Anterior-dorsal views. (D) pax3 expression in the
surface ectodermal A-P stripe, which indicates the hatching gland
progenitors(verticalarrows,HG) isrepressedonthexYAP-injectedside.In
contrast, pax3 expression in the underlying neural crest progenitors is
expanded (see Figure 6A). Dorsal view. (E) six1 expression in the otocyst
(bracket) is reduced on the xYAP-injected side (right panel) compared to
the uninjected side(Un)ofthe sameembryo (left panel).Sideviews,stage
26.(F)ThemigratorypathoffoxD3-expressingneuralcrestcells(indicated
by brackets) is truncated on the xYAP-injected side (right). Frontal view,
stage 24. (G) neuroD expression in the trigeminal placode (bracket) is
reduced on the xYAP-injected side (right panel) compared to the
uninjected side (Un) of the same embryo (left panel). Side views, stage 22.
doi:10.1371/journal.pone.0020309.g005
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neural, hatching gland, PPE, epidermal, and somitic muscle dif-
ferentiation, we performed a series of structure-function analyses
whereby mutant forms of xYAP (Figure 8A) were expressed on
one side of the embryo (Table 1). The constitutively active form
of xYAP (cActive xYAP), in which the LATS phosphorylation site
is mutated rendering the protein unable to exit the nucleus,
caused expansion of neural plate (sox2) and neural crest (pax3)
progenitors and reduction of pax3
+ hatching gland precursors at
frequencies comparable to wild type xYAP (Figure 8B, C). These
results confirm that the nuclear activity of YAP is required for
these phenotypes. In contrast, deletion of the TEAD-binding site
(TBS), WW domains, N-terminus, or C-terminus each resulted in
a dramatic (sox2) to moderate (pax3-NCP, pax3-HG) reduction in
the frequency of the respective phenotypes, indicating that an
intact protein is required. These results implicate the importance
of multiple binding partners, not solely the interaction with
TEAD. In contrast, loss of neural plate differentiation (p27
xic1)
and formation of the PPE (sox11) were maintained at high
frequencies with each xYAP mutant, indicating that interactions
at one or more of the remaining domains are sufficient to down-
regulate these genes. Interestingly xYAP-mediated loss of epider-
mal (cyto-keratin) and somitic muscle (myoD) differentiation were
specifically reduced by deletion of its PDZ-binding motif. These
results implicate the involvement of a PDZ-containing interacting
protein in the effects on these two tissues. The requirements for
different YAP domains for the effects on these diverse embryonic
tissues indicate that different binding partners are likely to
mediate them.
Discussion
YAP is well conserved
Through evolution, proteins within the WW domain-containing
family have functionally diversified. Although no YAP homologue
exists in yeast, its closest YAP relative, Rsp5, is a WW-containing
protein exhibiting ubiquitin ligase activity. The Drosophila YAP
homologue, Yorkie, exhibits little sequence conservation when
aligned with its vertebrate YAP counterparts, especially at its C-
terminal end where this protein lacks the conserved vertebrate
transcriptional activation domain and the SH3- and PDZ-binding
motifs. However, other invertebrates, such as the acorn worm,
honeybee, wasp, sea anemone, sea urchin, and sea squirt, which
also exhibit low vertebrate YAP identity (,40%), do possess the
PDZ-binding motif. In order to utilize frog and fish to elucidate a
common functional role in vertebrate development, it is important
to establish that the YAP proteins in these animals contain similar
functional domains. Indeed, xYAP and zYAP are 78% identical to
the mouse homologue and contain all of the functional domains
described inmammals (see also[36],[40]).Interestingly,the proline-
rich region present at the N-terminus of the human homologue,
which allows for hnRNP U binding, contains fewer prolines in non-
mammals (human, 18; mouse, 15; frog, 6; zebrafish, 3).
The functional diversity of YAP in vivo, however, is just now
beginning to be unraveled. In particular, there is a paucity of
information regarding its function in early vertebrate develop-
mental processes. Previously, we reported that mice lacking YAP
exhibit severe developmental phenotypes that result in early
lethality [15]. Given that the A-P axis defects may result from the
Figure 6. xYAP expands pax3-expressing neural crest progenitors. (A) The pax3-expressing neural crest progenitor field (NCP) is darker,
longer, and/or wider (bracket) on the xyap-injected side. Dorsal view, stage 15. (B) xYAP MO-mediated knockdown (40 ng) eliminated pax3
expression in both neural crest progenitors and hatching gland (HG) precursors. Addition of exogenous xyap (YAP MO + xyap) rescued pax3
expression in neural crest progenitors (NCP), but not in hatching gland. Dorsal views, stage 17. (C) xyap mRNA injection into the precursor blastomere
of the intermediate mesoderm does not cause pax3 expansion on the injected side (left panel, dorsal view). Right panel (posterior view, dorsal is
down) shows part of the lineage labeled clone (red) denoting the injected side. (D) tead1 mRNA injection (100 pg) expands pax3-expressing neural
crest progenitors (NCP) at a moderate frequency. xyap mRNA injection (100 pg) rarely expands this population. In combination (tead1/xyap, 100 pg
each), this population is expanded in nearly every embryo. The repression of the pax3-expressing hatching gland progenitors (HG) also was greatest
when TEAD/xYAP were co-expressed. Dorsal anterior views at stage 16.
doi:10.1371/journal.pone.0020309.g006
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models, Xenopus laevis and Danio rerio, to investigate the function of
YAP during early development. Herein, we provide the first
description of the mechanism by which YAP regulates the
completion of gastrulation and the elongation of the A-P body
axis. This protein is required for the proper timing of expression of
early mesodermal genes, and for the expansion of the sox2
+ neural
plate and pax3
+ neural crest progenitors at the neural plate border.
We demonstrate that the effects of YAP, a transcriptional co-
activator, on pax3
+ neural crest progenitors are accomplished, at
least in part, by co-regulation of the pax3 gene via interaction with
the transcription factor, TEAD1.
Figure 7. Endogenous xYAP resides at a novel 59 regulatory region of pax3. (A) A highly conserved putative TEAD-binding site (yellow
boxes) is present in the 59 regulatory region of the pax3 gene in 15 different vertebrates. A previously described mouse TEAD-binding site (red box)
appears less conserved. (B) Chromatin isolated from 300 wild type stage 14–16 Xenopus laevis embryos was sheared to a size range of 150 to 900
base pairs. (C) Chromatin immunoprecipitations (ChIPs) from 12.5 mgo r2 5mg of sheared chromatin immunoprecipitated a band at the expected size
for the putative novel TEAD1-binding site region with the hYAP antibody but not with a control IgG antibody. (D) Sequencing of this band from three
different clones verified that the genomic region pulled down by the hYAP anitbody contained the novel TEAD-binding site (yellow) when compared
to the Xenopus tropicalis genomic sequence.
doi:10.1371/journal.pone.0020309.g007
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We show that MO-mediated elimination of YAP in vivo resulted
in a failure of frog and fish embryos to complete the epiboly
movements of gastrulation, and a lower MO dose knockdown
reduced the elongation of the A-P body axis (this study, and [36]).
While germ layer inductions occurred in the absence of endo-
genous, zygotic xYAP protein expression, the onset of mesodermal
gene expression was perturbed, indicating that YAP is required
during the early steps of body axis formation. While the me-
chanism is not known, these results demonstrate that the similar
defects described in mice lacking YAP are not simply due to
nutritional deficiencies.
Increasing YAP expands progenitors and inhibits their
differentiation
When wild type xyap, myap,o rhyap RNAs were injected into
Xenopus laevis embryos, major morphological defects became
apparent at tail bud stages. Because the tissue perturbations were
widespread, we predicted that gene expression changes occurred
during earlier patterning events. In fact, we observed that at neural
plate stages two progenitor populations were expanded (sox2
+
neural plate; pax3
+ neural crest), whereas differentiation markers of
these tissues as well as of somitic muscle and epidermis were
repressed. These results are consistent with reports that over-
expression of YAP expands mouse small intestinal progenitors
[44] and chick neural tube sox2
+ neural progenitors [41]. The
mechanism by which the expansion of neural progenitors in frog
embryos is accomplished is not yet known. The expansion of
mouse intestinal progenitors is mediated by activation of the Notch
pathway by YAP [44]; however, frog embryos injected with xyap
mRNA showed reduced notch and hes1 RNA expression. Inter-
estingly, xYAP did not expand all progenitors or all pax3-
expressing cells. YAP gain-of-function inhibited pax3 expression
in hatching gland precursors, and reduced the expression of six1,a
transcription factor that maintains the PPE in a progenitor state
[52,59]. These results demonstrate that YAP-mediated expansion
of progenitor populations has tissue specificity, even within the
embryonic ectoderm. The mechanisms by which YAP gain-of-
function and loss-of-function both result in a shortened axis are not
known. One possibility is that YAP loss-of-function leads to a loss
of the progenitor pool, as we show for sox2 and pax3, whereas YAP
gain-of-function extends the time cells spend in a progenitor,
undifferentiated state. In both cases, there would be a reduction in
differentiated cells.
xYAP directly regulates pax3 transcription
The effects of altering YAP levels on pax3 expression in the
neural crest progenitors suggested that YAP directly regulates pax3
transcription. Increasing evidence suggests that the interaction of
YAP with the TEAD family of transcription factors is critically
important for proper vertebrate development, [34,37,41,60], in-
cluding neural progenitor expansion [41]. Therefore, we searched
for highly conserved TEAD-binding sites in the 59 regulatory
Figure 8. xYAP deletion mutants exhibit differential activities. (A) Cartoons of the xYAP mutants created to determine which protein-protein
interaction domain(s) is important for the in vivo gain-of-function phenotypes described in Figures 4–6.Deletionsormutations are indicatedbycolor loss:
the TEAD-binding site (xYAPDTBS, purple), the LATS phosphorylation site (cActive xYAP, orange), the two WW domains (xYAPDWW, red), the N-terminus
(xYAP, DN-term) containing both the hnRNP U and TEAD-binding sites, and the PDZ-binding motif (xYAPDC-term, fuchsia) at the C-terminus. (B)T h e
percentage of embryos showing expansion of sox2-expressing neural plate cells or expansion of pax3-expressing neural crest progenitor (NCP) cells after
injection of each of the mutant forms of xYAP. Note that cActive xYAP, which prevents YAP from leaving the nucleus, is as effective as wild type YAP.
However, all other mutant forms reduce this phenotype. Sample sizes are presented in Table 1. (C) The percentage of embryos showing reduced gene
expression after injection of each mutant form of xYAP. Deletion of the WW domains or of the PDZ-binding motif interfered the most with repression of
pax3
+ hatching gland (HG) progenitors. Loss of neural plate differentiation (p27
xic1) and a PPE marker (sox11) were maintained at high frequencies with
each xYAP mutant, indicating that interactions at one or more of the remaining domains are sufficient to downregulate these genes. However, xYAP-
mediated loss of somitic muscle (myoD)a n de p i d e r m a l( cyto-keratin) differentiation was specifically reduced by deletion of its PDZ-binding motif.
doi:10.1371/journal.pone.0020309.g008
Table 1. xYAP deletion mutants exhibit differential activities.
Probe RNA Injected % Change
sox2 xYAP n=22, 73% expanded
sox2 cActive xYAP n-20, 85% expanded
sox2 xYAP D TBS n=42, 19% expanded
sox2 xYAP D WW n=62, 11% expanded
sox2 xYAP D N-term n=18, 0% expanded
pax3 (NCP) xYAP n=51, 65% expanded
pax3 (NCP) cActive xYAP n=19, 74% expanded
pax3 (NCP) xYAP D TBS n=68, 48% expanded
pax3 (NCP) xYAP D WW n=64, 45% expanded
pax3 (NCP) xYAP D N-term n=16, 50% expanded
pax3 (NCP) xYAP D C-term n=18, 38% expanded
pax3 (HG) xYAP n=41, 90% reduced
pax3 (HG) cActive xYAP n=17, 76% reduced
pax3 (HG) xYAP D TBS n=68, 83% reduced
pax3 (HG) xYAP D WW n=67, 54% reduced
pax3 (HG) xYAP D N-term n=8, 100% reduced
pax3 (HG) xYAP D C-term n=13, 54% reduced
p27
xic1 xYAP n=25, 98% reduced
p27
xic1 xYAP D TBS n=35, 83% reduced
p27
xic1 xYAP D WW n=42, 79% reduced
p27
xic1 xYAP D N-term n=35, 69% reduced
p27
xic1 xYAP D C-term n=35, 69% reduced
sox11 xYAP n=35, 89% reduced
sox11 xYAP D TBS n=31, 90% reduced
sox11 xYAP D WW n=33, 82% reduced
sox11 xYAP D N-term n=34, 94% reduced
sox11 xYAP D C-term n=35, 91% reduced
myoD xYAP n=52, 68% reduced
myoD xYAP D TBS n=34, 100% reduced
myoD xYAP D WW n=81, 80% reduced
myoD xYAP D N-term n=71, 58% reduced
myoD xYAP D C-term n=50, 19% reduced
cyto-keratin xYAP n=32, 100% reduced
cyto-keratin xYAP D TBS n=42, 100% reduced
cyto-keratin xYAP D WW n=47, 100% reduced
cyto-keratin xYAP D N-term n=41, 100% reduced
cyto-keratin xYAP D C-term n=38, 0.03% reduced
Sample sizes and frequencies of genes that were expanded (sox2, pax3+ neural
crest progenitors [NCP]) or reduced (pax3+ hatching gland [HG] progenitors,
p27xic1, sox11, myoD, and cyto-keratin) after injection of wild type xyap or
mutant (defined in Fig. 8A) xyap mRNAs.
doi:10.1371/journal.pone.0020309.t001
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site within this region. Increased expression of TEAD1 phenocop-
ied the xYAP-mediated expansion of pax3 in the neural crest
progenitors and significantly enhanced this phenotype following
coexpression of xtead1 with levels of xyap mRNA that were
ineffective on their own. Importantly, we demonstrated the in vivo
relevance of this predicted association by ChIP analysis.
Endogenous YAP localized to this newly identified TEAD-binding
site within the 59 regulatory region of pax3, but not to a region of
the pax3 promoter lacking putative TEAD-binding sites (Figure
S4A). In addition, a region of the sox2 promoter containing a
putative TEAD-binding site also did not co-immunoprecipitate
with YAP (Figure S4B), even though in chick neural tube YAP and
TEAD1 appear to co-regulate sox2 expression [41]. We have yet to
confirm whether endogenous TEAD1 resides on this region or
whether other TEADs are present. For example, there is evidence
that TEAD1 and TEAD2 can functionally compensate for each
other in early mouse development [61,62]. Nonetheless, these
experiments demonstrate a new developmental role for both
TEAD and YAP in cooperatively driving pax3 expression in neural
crest progenitors.
Our structure/function analyses, however, indicate that the
expansion of the pax3 neural crest progenitors likely involves YAP
binding to proteins in addition to TEADs, because deletion of
other domains also reduced this effect. In fact, the different effects
of YAP on different ectodermal and mesodermal genes appear to
require different protein interaction domains, confirming that the
ability of YAP to bind to multiple, diverse proteins endows this
protein with multiple diverse functions. Here, we have illuminated
a few key developmental roles for YAP, which appear to be
consistent across three vertebrates. Moving forward, it will be
interesting to see whether it is YAP’s transcriptional activation
abilities or its function as a scaffolding protein that is more
important for each specific effect. An intriguing notion is that YAP
may act as a critical scaffolding protein within the nucleus to assist
in the regulation of transcription or regulate the state and/or
remodeling of chromatin.
Supporting Information
Figure S1 mRNA and protein expression of xYAP during
Xenopus laevis development. RT-PCR analyses showed that
xyap RNA was maternally expressed in an unfertilized egg and
early cleavage (stage 3), decreases slightly between late cleavage
(stage 6) and the mid-blastula transition (stage 9), but was then
expressed abundantly through subsequent stages of Xenopus laevis
development through feeding tadpole (stage 40). The (+) indicates
lanes that included reverse transcriptase in the RT-PCR reaction,
while the (2) indicates lanes that lacked the reverse transcriptase in
the RT-PCR reaction. Western blot analysis showed that xYAP
protein was maternally present at cleavage stages (stages 2–7), was
detectable at the onset of epiboly and gastrulation (stages 9–10),
and increased dramatically from mid-gastrula (stage 11) onwards.
The (+) represents the positive control lane, which contains a cold
in vitro translated xYAP product.
(TIF)
Figure S2 Efficacy of xYAP splice blocking MOs. xYAP
splice blocking MOs (40 or 80 ng) did not completely knockdown
endogenous YAP protein. YAP protein was reduced 60–66%
when compared to the control MO lanes. This correlates with the
xYAP splice blocking MOs causing a less penetrant open-blas-
topore phenotype compared to the MOs targeted to the trans-
lational start site.
(TIF)
Figure S3 Western blot analysis confirms overexpres-
sion and proper translation of various yap mRNAs. Using
antibodies against the HA tag (left side) or hYAP (right side),
immunoblots (IB) of stage 15 whole Xenopus laevis embryo lysates
illustrated proper over-expression of xYAP, mYAP, and hYAP
after mRNA injections at the 1-cell stage. Injected mRNAs are
translated more efficiently than endogenous mRNA, accounting
for an apparent lack of product in the ‘‘uninjected’’ lane of the
YAP IB. However, see Figures 1B and S1 for endogenous YAP
expression detected with this antibody.
(TIF)
Figure S4 YAP does not co-immunoprecipitate with two
other regions of Xenopus laevis genomic DNA. (A)
Another region of the pax3 promoter, not containing putative
TEAD-binding sequences, failed to co-immunoprecipitate with
YAP or the control IgG, yet a band of the expected size was
amplified in the input lane. (B) A region of the sox2 promoter,
containing a putative TEAD-binding site, did not co-immunopre-
cipitate with YAP or the control IgG, yet a band of the expected
size was amplified in the input lane.
(TIF)
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